398 related articles for article (PubMed ID: 9092481)
1. Potent inhibition of HIV-1 infectivity in macrophages and lymphocytes by a novel CCR5 antagonist.
Simmons G; Clapham PR; Picard L; Offord RE; Rosenkilde MM; Schwartz TW; Buser R; Wells TN; Proudfoot AE
Science; 1997 Apr; 276(5310):276-9. PubMed ID: 9092481
[TBL] [Abstract][Full Text] [Related]
2. C-C chemokines released by lipopolysaccharide (LPS)-stimulated human macrophages suppress HIV-1 infection in both macrophages and T cells.
Verani A; Scarlatti G; Comar M; Tresoldi E; Polo S; Giacca M; Lusso P; Siccardi AG; Vercelli D
J Exp Med; 1997 Mar; 185(5):805-16. PubMed ID: 9120386
[TBL] [Abstract][Full Text] [Related]
3. Macrophage-tropic HIV induces and exploits dendritic cell chemotaxis.
Lin CL; Sewell AK; Gao GF; Whelan KT; Phillips RE; Austyn JM
J Exp Med; 2000 Aug; 192(4):587-94. PubMed ID: 10952729
[TBL] [Abstract][Full Text] [Related]
4. Nonproductive human immunodeficiency virus type 1 infection of human fetal astrocytes: independence from CD4 and major chemokine receptors.
Sabri F; Tresoldi E; Di Stefano M; Polo S; Monaco MC; Verani A; Fiore JR; Lusso P; Major E; Chiodi F; Scarlatti G
Virology; 1999 Nov; 264(2):370-84. PubMed ID: 10562499
[TBL] [Abstract][Full Text] [Related]
5. Coreceptor competition for association with CD4 may change the susceptibility of human cells to infection with T-tropic and macrophagetropic isolates of human immunodeficiency virus type 1.
Lee S; Lapham CK; Chen H; King L; Manischewitz J; Romantseva T; Mostowski H; Stantchev TS; Broder CC; Golding H
J Virol; 2000 Jun; 74(11):5016-23. PubMed ID: 10799575
[TBL] [Abstract][Full Text] [Related]
6. Expression and use of human immunodeficiency virus type 1 coreceptors by human alveolar macrophages.
Worgall S; Connor R; Kaner RJ; Fenamore E; Sheridan K; Singh R; Crystal RG
J Virol; 1999 Jul; 73(7):5865-74. PubMed ID: 10364338
[TBL] [Abstract][Full Text] [Related]
7. CC CKR5: a RANTES, MIP-1alpha, MIP-1beta receptor as a fusion cofactor for macrophage-tropic HIV-1.
Alkhatib G; Combadiere C; Broder CC; Feng Y; Kennedy PE; Murphy PM; Berger EA
Science; 1996 Jun; 272(5270):1955-8. PubMed ID: 8658171
[TBL] [Abstract][Full Text] [Related]
8. Tat protein induces human immunodeficiency virus type 1 (HIV-1) coreceptors and promotes infection with both macrophage-tropic and T-lymphotropic HIV-1 strains.
Huang L; Bosch I; Hofmann W; Sodroski J; Pardee AB
J Virol; 1998 Nov; 72(11):8952-60. PubMed ID: 9765440
[TBL] [Abstract][Full Text] [Related]
9. Aminooxypentane-RANTES induces CCR5 internalization but inhibits recycling: a novel inhibitory mechanism of HIV infectivity.
Mack M; Luckow B; Nelson PJ; Cihak J; Simmons G; Clapham PR; Signoret N; Marsh M; Stangassinger M; Borlat F; Wells TN; Schlöndorff D; Proudfoot AE
J Exp Med; 1998 Apr; 187(8):1215-24. PubMed ID: 9547333
[TBL] [Abstract][Full Text] [Related]
10. Isolated human astrocytes are not susceptible to infection by M- and T-tropic HIV-1 strains despite functional expression of the chemokine receptors CCR5 and CXCR4.
Boutet A; Salim H; Taoufik Y; Lledo PM; Vincent JD; Delfraissy JF; Tardieu M
Glia; 2001 May; 34(3):165-77. PubMed ID: 11329179
[TBL] [Abstract][Full Text] [Related]
11. Genetic subtype-independent inhibition of human immunodeficiency virus type 1 replication by CC and CXC chemokines.
Trkola A; Paxton WA; Monard SP; Hoxie JA; Siani MA; Thompson DA; Wu L; Mackay CR; Horuk R; Moore JP
J Virol; 1998 Jan; 72(1):396-404. PubMed ID: 9420238
[TBL] [Abstract][Full Text] [Related]
12. Adaptation to promiscuous usage of CC and CXC-chemokine coreceptors in vivo correlates with HIV-1 disease progression.
Xiao L; Rudolph DL; Owen SM; Spira TJ; Lal RB
AIDS; 1998 Sep; 12(13):F137-43. PubMed ID: 9764773
[TBL] [Abstract][Full Text] [Related]
13. Effect of beta-chemokines on human immunodeficiency virus type 1 replication, binding, uncoating, and CCR5 receptor expression in human monocyte-derived macrophages.
Jiang Y; Jolly PE
J Hum Virol; 1999; 2(3):123-32. PubMed ID: 10413363
[TBL] [Abstract][Full Text] [Related]
14. Mechanisms involved in stimulation of human immunodeficiency virus type 1 replication by aminooxypentane RANTES.
Marozsan AJ; Torre VS; Johnson M; Ball SC; Cross JV; Templeton DJ; Quiñones-Mateu ME; Offord RE; Arts EJ
J Virol; 2001 Sep; 75(18):8624-38. PubMed ID: 11507208
[TBL] [Abstract][Full Text] [Related]
15. The second extracellular loop of CCR5 is the major determinant of ligand specificity.
Samson M; LaRosa G; Libert F; Paindavoine P; Detheux M; Vassart G; Parmentier M
J Biol Chem; 1997 Oct; 272(40):24934-41. PubMed ID: 9312096
[TBL] [Abstract][Full Text] [Related]
16. Agonist-induced internalization of CC chemokine receptor 5 as a mechanism to inhibit HIV replication.
Ferain T; Hoveyda H; Ooms F; Schols D; Bernard J; Fraser G
J Pharmacol Exp Ther; 2011 Jun; 337(3):655-62. PubMed ID: 21389095
[TBL] [Abstract][Full Text] [Related]
17. Role of CCR5 in infection of primary macrophages and lymphocytes by macrophage-tropic strains of human immunodeficiency virus: resistance to patient-derived and prototype isolates resulting from the delta ccr5 mutation.
Rana S; Besson G; Cook DG; Rucker J; Smyth RJ; Yi Y; Turner JD; Guo HH; Du JG; Peiper SC; Lavi E; Samson M; Libert F; Liesnard C; Vassart G; Doms RW; Parmentier M; Collman RG
J Virol; 1997 Apr; 71(4):3219-27. PubMed ID: 9060685
[TBL] [Abstract][Full Text] [Related]
18. The LD78beta isoform of MIP-1alpha is the most potent CC-chemokine in inhibiting CCR5-dependent human immunodeficiency virus type 1 replication in human macrophages.
Aquaro S; Menten P; Struyf S; Proost P; Van Damme J; De Clercq E; Schols D
J Virol; 2001 May; 75(9):4402-6. PubMed ID: 11287590
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of HIV-1 replication by GB virus C infection through increases in RANTES, MIP-1alpha, MIP-1beta, and SDF-1.
Xiang J; George SL; Wünschmann S; Chang Q; Klinzman D; Stapleton JT
Lancet; 2004 Jun; 363(9426):2040-6. PubMed ID: 15207954
[TBL] [Abstract][Full Text] [Related]
20. The CXC chemokine SDF-1 is the ligand for LESTR/fusin and prevents infection by T-cell-line-adapted HIV-1.
Oberlin E; Amara A; Bachelerie F; Bessia C; Virelizier JL; Arenzana-Seisdedos F; Schwartz O; Heard JM; Clark-Lewis I; Legler DF; Loetscher M; Baggiolini M; Moser B
Nature; 1996 Aug; 382(6594):833-5. PubMed ID: 8752281
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
